Skip to main content

Liver Transplantation: An Overview

  • Chapter
  • First Online:
  • 1600 Accesses

Abstract

Orthotopic liver transplantation (OLT) is a definitive life-saving treatment for irreversible liver failure and specific types of liver and bile duct cancers in the absence of systemic metastasis. Donor availability is the principal limiting factor for expansion of OLT. With scarcity of organs for transplantation, the current Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease (MELD/PELD) liver allocation system prioritizes the organ based on medical urgency to decrease patient death rate while on the liver transplant waiting list. In short, the deceased donor liver graft is allocated to the sickest patient on the waiting list based on the patient’s MELD score.

Long-term patient survival outcomes after orthotopic liver transplantation (OLT) are excellent largely because of surgical innovations and advances in peri- and intraoperative management and immunosuppression regimens. The rate of patient recovery is generally dependent of the patient’s acuity of illness prior to OLT, operative factors, and hepatic allograft function. After primary (first time) OLT, 10–22 % of OLT recipients would require retransplantation of the liver (ReLT) due to various reasons. The most common early causes of graft failure leading to ReLT are primary nonfunction (PNF), delayed nonfunction or initial poor function, and vascular complications while chronic rejection and recurrence of primary liver disease are common late causes of graft failure. This chapter aims to address common general topics in the current clinical practice of liver transplantation.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, et al. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg. 2013;258(3):409–21.

    Article  PubMed  Google Scholar 

  2. Farmer DG, Venick RS, McDiarmid SV, Ghobrial RM, Gordon SA, Yersiz H, et al. Predictors of outcomes after pediatric liver transplantation: an analysis of more than 800 cases performed at a single institution. J Am Coll Surg. 2007;204(5):904–14. discussion 14–6.

    Article  PubMed  Google Scholar 

  3. Hong JC, Yersiz H, Farmer DG, Duffy JP, Ghobrial RM, Nonthasoot B, et al. Longterm outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases. J Am Coll Surg. 2009;208(5):682–9. discussion 9–91.

    Article  PubMed  Google Scholar 

  4. Saab S, Bownik H, Ayoub N, Younossi Z, Durazo F, Han S, et al. Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors. Liver Transpl. 2011;17(5):580–90.

    Article  PubMed  Google Scholar 

  5. Duffy JP, Kao K, Ko CY, Farmer DG, McDiarmid SV, Hong JC, et al. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg. 2010;252(4):652–61.

    PubMed  Google Scholar 

  6. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl. 2000;6(5):553–61.

    Article  CAS  PubMed  Google Scholar 

  7. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology. 1996;110(1):167–77.

    Article  CAS  PubMed  Google Scholar 

  8. Recommendations for testing, managing, and treating hepatitis C: the American Association for the Study of Liver Diseases and The Infectious Diseases Society of America. Available from: http://hcvguidelines.org/.

  9. Perrillo R, Buti M, Durand F, Charlton M, Gadano A, Cantisani G, et al. Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B. Liver Transpl. 2013;19(8):887–95.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lee WM, Squires Jr RH, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47(4):1401–15.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–55.

    Article  PubMed  Google Scholar 

  12. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118–27.

    Article  CAS  PubMed  Google Scholar 

  13. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–24.

    Article  PubMed  Google Scholar 

  14. Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011;17 Suppl 2:S44–57.

    Article  PubMed  Google Scholar 

  15. Renshaw K. Malignant neoplasms of the extrahepatic biliary ducts. Ann Surg. 1922;76(2):205–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet. 1997;350(9085):1142–3.

    Article  CAS  PubMed  Google Scholar 

  17. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33(6):1353–7.

    Article  CAS  PubMed  Google Scholar 

  18. Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc. 2009;41(10):4023–35.

    Article  CAS  PubMed  Google Scholar 

  19. Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg. 2011;146(6):683–9.

    Article  PubMed  Google Scholar 

  20. Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, et al. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg. 2011;212(4):514–20. discussion 20–1.

    Article  PubMed  Google Scholar 

  21. U.S. Department of Health and Human Services HRaSA, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD. Allocation Calculators. Available from: http://optn.transplant.hrsa.gov/converge/resources/allocationcalculators.asp.

  22. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–6.

    Article  PubMed  Google Scholar 

  23. Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant. 2009;9(4 Pt 2):970–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Toso C, Dupuis-Lozeron E, Majno P, Berney T, Kneteman NM, Perneger T, et al. A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list. Hepatology. 2012;56(1):149–56.

    Article  PubMed  Google Scholar 

  25. Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E, et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut. 2002;50(1):123–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology. 2005;41(5):1122–9.

    Article  PubMed  Google Scholar 

  27. Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, et al. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut. 2011;60(5):702–9.

    Article  PubMed  Google Scholar 

  28. Agopian VG, Dhillon A, Baber J, Kaldas FM, Zarrinpar A, Farmer DG, et al. Liver transplantation in recipients receiving renal replacement therapy: outcomes analysis and the role of intraoperative hemodialysis. Am J Transplant. 2014;14(7):1638–47.

    Article  CAS  PubMed  Google Scholar 

  29. Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, et al. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012;12(11):2901–8.

    Article  CAS  PubMed  Google Scholar 

  30. Nadim MK, Davis CL, Sung R, Kellum JA, Genyk YS. Simultaneous liver-kidney transplantation: a survey of US transplant centers. Am J Transplant. 2012;12(11):3119–27.

    Article  CAS  PubMed  Google Scholar 

  31. Nguyen NT, Harring TR, Goss JA, O’Mahony CA. Neuroendocrine liver metastases and orthotopic liver transplantation: the US experience. Int J Hepatol. 2011;2011:742890.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369(26):2525–34.

    Article  CAS  PubMed  Google Scholar 

  33. Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11(12):1581–9.

    Article  PubMed  Google Scholar 

  34. Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, et al. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2008;14(9):1273–80.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Uchiyama H, Mano Y, Taketomi A, Soejima Y, Yoshizumi T, Ikegami T, et al. Kinetics of anti-blood type isoagglutinin titers and B lymphocytes in ABO-incompatible living donor liver transplantation with rituximab and plasma exchange. Transplantation. 2011;92(10):1134–9.

    Article  CAS  PubMed  Google Scholar 

  36. Yersiz H, Lee C, Kaldas FM, Hong JC, Rana A, Schnickel GT, et al. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. Liver Transpl. 2013;19(4):437–49.

    Article  PubMed  Google Scholar 

  37. Reich DJ, Hong JC. Current status of donation after cardiac death liver transplantation. Curr Opin Organ Transplant. 2010;15(3):316–21.

    Article  PubMed  Google Scholar 

  38. Hong JC, Yersiz H, Kositamongkol P, Xia VW, Kaldas FM, Petrowsky H, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg. 2011;146(9):1017–23.

    Article  PubMed  Google Scholar 

  39. Merion RM, Pelletier SJ, Goodrich N, Englesbe MJ, Delmonico FL. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg. 2006;244(4):555–62.

    PubMed  PubMed Central  Google Scholar 

  40. Hong JC, Yersiz H, Busuttil RW. Where are we today in split liver transplantation? Curr Opin Organ Transplant. 2011;16(3):269–73.

    Article  PubMed  Google Scholar 

  41. Kim J, Zimmerman MA. Technical aspects for live-donor organ procurement for liver, kidney, pancreas, and intestine. Curr Opin Organ Transplant. 2015;20(2):133–9.

    Article  PubMed  Google Scholar 

  42. Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology. 2008;135(2):468–76.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, et al. Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant. 2012;12(5):1208–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Chan SC, Fan ST, Lo CM, Liu CL, Wong J. Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases. Ann Surg. 2007;245(1):110–7.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Hashikura Y, Ichida T, Umeshita K, Kawasaki S, Mizokami M, Mochida S, et al. Donor complications associated with living donor liver transplantation in Japan. Transplantation. 2009;88(1):110–4.

    Article  PubMed  Google Scholar 

  46. Duffy JP, Hong JC, Farmer DG, Ghobrial RM, Yersiz H, Hiatt JR, et al. Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg. 2009;208(5):896–903. discussion 903–5.

    Article  PubMed  Google Scholar 

  47. Petrowsky H, Rana A, Kaldas FM, Sharma A, Hong JC, Agopian VG, et al. Liver transplantation in highest acuity recipients: identifying factors to avoid futility. Ann Surg. 2014;259(6):1186–94.

    Article  PubMed  Google Scholar 

  48. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ. Liver transplantation in the United States, 1999-2008. Am J Transplant. 2010;10(4 Pt 2):1003–19.

    Article  CAS  PubMed  Google Scholar 

  49. Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg. 2000;232(4):490–500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005;241(6):905–16. discussion 16–8.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Uemura T, Randall HB, Sanchez EQ, Ikegami T, Narasimhan G, McKenna GJ, et al. Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl. 2007;13(2):227–33.

    Article  PubMed  Google Scholar 

  52. Hong JC, Kosari K, Benjamin E, Duffy JP, Ghobrial RM, Farmer DG, et al. Does race influence outcomes after primary liver transplantation? A 23-year experience with 2,700 patients. J Am Coll Surg. 2008;206(5):1009–16. discussion 16–8.

    Article  PubMed  Google Scholar 

  53. Hong JC, Kaldas FM, Kositamongkol P, Petrowsky H, Farmer DG, Markovic D, et al. Predictive index for long-term survival after retransplantation of the liver in adult recipients: analysis of a 26-year experience in a single center. Ann Surg. 2011;254(3):444–8. discussion 8–9.

    Article  PubMed  Google Scholar 

  54. Hong JC. Outcomes predictors in transplantation. In: Busuttil RW, Klintmalm GBG, editors. Transplantation of the liver. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2015. p. 1366–78.

    Chapter  Google Scholar 

  55. Choi EK, Lu DS, Park SH, Hong JC, Raman SS, Ragavendra N. Doppler US for suspicion of hepatic arterial ischemia in orthotopically transplanted livers: role of central versus intrahepatic waveform analysis. Radiology. 2013;267(1):276–84.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johnny C. Hong M.D., F.A.C.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kim, J., Hong, J.C. (2017). Liver Transplantation: An Overview. In: Saeian, K., Shaker, R. (eds) Liver Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-30103-7_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30103-7_36

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30101-3

  • Online ISBN: 978-3-319-30103-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics